Here's some of what we've been reading lately. We hope you find these articles to be interesting and helpful.
Markets come to grips with the Fed on interest rates (Wall Street Journal). "Traders give up on hopes for a central-bank policy pivot — for now."
Here come the 5% CDs (Brett Arends, Marketwatch). As always, you'll find the best deals by shopping around.
The Conference Board Leading Economic Index® (LEI) for the U.S. declined again in January (News release via Morningstar). "[We still expect] high inflation, rising interest rates, and contracting consumer spending to tip the US economy into recession in 2023."
Growth stocks are trumping value once again (Wall Street Journal). But economic clouds could overtake growth’s day in the sun.
Value stocks? Growth stocks? Markets last year turned everything topsy-turvy. (New York Times via Fidelity). Perhaps Amazon and Google should now be in the "value" category, while Exxon and Chevron should be considered "growth."
CBO warns of sharp uptick in Social Security, Medicare spending (The Hill). The Congressional Budget Office estimates annual combined spending on Social Security and Medicare will reach nearly $4 trillion within a decade.
What's in it for me? (Adam Grossman, Humble Dollar). A summary of the more prominent provisions of the "SECURE Act version 2.0," signed into law in the waning days of 2022.
Crypto investors brace for more crackdowns from regulators (Wall Street Journal). Related: Crypto layoffs and bankruptcies in 2023: Here's the list to watch.
How to write an appeal letter to your health insurance provider (GoodRx). This article also notes that even if the insurance company denies your appeal, you have the right, under law, to appeal to an independent third party.
Your comments are always welcome. Join the discussion below!